在有败血症和败血栓冲击的通风患者中进行最佳镇静
Annachiara Marra1, Ryan J Smith2, Pratik P Pandharipande3
1Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples "Federico II", Naples, Italy.
对于需要机械通风的败血症和败血性休克患者,建议采用止痛治疗的方法. 应谨慎使用诸如普罗波福和德克斯梅德托米丁等镇静剂,对高剂量镇静剂策略需要进一步研究.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 重症监护室的重症监护室是重症监护室的重症监护室.
背景情况:
- 对于患有败血症和败血症休克的患者,机械通风通常是必要的.
- 镇静对于这种脆弱的患者群体耐受机械通风至关重要.
- 适当的镇静策略至关重要,以优化患者的治疗结果,并最大限度地减少并发症.
研究的目的:
- 审查当前对败血症和败血性休克患者镇静和镇痛的建议.
- 为了突出首选的镇静剂和剂量策略.
- 确定需要进一步研究的领域,以管理危急病患者的镇静.
主要方法:
- 审查关键护理医学学会的指导方针和建议.
- 对用于止痛和镇静的首选药物的分析,包括普罗波福和德克斯梅德托米丁.
- 讨论"评估,预防和管理疼痛,自发唤醒试验和自发呼吸试验,疼痛缓解和镇静的选择,妄想:评估,预防和管理,早期运动和运动,以及家庭参与和赋权"的捆绑.
主要成果:
- 建议采用止痛第一方法,根据需要服用镇静剂.
- 普罗波福和德克斯梅德托米丁被确定为首选的镇静剂.
- 在这种患者群体中,建议谨慎使用镇静剂剂量策略.
结论:
- 目前的证据支持一种先止痛的策略,用于在机械通风中镇静血症和败血症休克患者.
- 建议使用propofol和dexmedetomidine,与已建立的重症监护包保持一致.
- 需要进一步的研究,以确定在这个人群中更高剂量的镇静剂需求的最佳实践.
更多相关视频
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
相关概念视频
Parenteral Anesthetics: Overview
Stages of General Anesthesia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Inhalational Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
